SELLAS Life Sciences Group, Inc. Development Agreements
2 Contracts & Agreements
- Novel RNAi Compounds, referred to as rxRNAtm compounds, that are distinct from, and we believe convey significant advantages over classic siRNA (conventionally-designed small... (Filed With SEC on March 31, 2010)
- Novel RNAi Compounds, referred to as rxRNAtm compounds, that are distinct from, and we believe convey significant advantages over classic siRNA (conventionally-designed small... (Filed With SEC on March 31, 2010)